These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31481983)

  • 1. Assessment of the SFlt-1 and sFlt-1/25(OH)D Ratio as a Diagnostic Tool in Gestational Hypertension (GH), Preeclampsia (PE), and Gestational Diabetes Mellitus (GDM).
    Walentowicz-Sadlecka M; Domaracki P; Sadlecki P; Siodmiak J; Grabiec M; Walentowicz P; Moliz MTA; Odrowaz-Sypniewska G
    Dis Markers; 2019; 2019():5870239. PubMed ID: 31481983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
    Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
    Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum strontium levels and altered oxidative stress status in early-onset preeclampsia.
    Barneo-Caragol C; Martínez-Morillo E; Rodríguez-González S; Lequerica-Fernández P; Vega-Naredo I; Álvarez FV
    Free Radic Biol Med; 2019 Jul; 138():1-9. PubMed ID: 31055131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
    Zhu X; Chen L; Li R
    Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
    Hirashima C; Ohkuchi A; Takahashi K; Suzuki H; Yoshida M; Ohmaru T; Eguchi K; Ariga H; Matsubara S; Suzuki M
    Hypertens Res; 2011 Feb; 34(2):212-7. PubMed ID: 21048778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of soluble fms-like tyrosine kinase-1/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women.
    Hanson E; Rull K; Ratnik K; Vaas P; Teesalu P; Laan M
    J Perinat Med; 2022 Sep; 50(7):939-946. PubMed ID: 35551712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Flt-1 as a diagnostic marker of pre-eclampsia.
    Woolcock J; Hennessy A; Xu B; Thornton C; Tooher J; Makris A; Ogle R
    Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):64-70. PubMed ID: 18275574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboelastography (TEG) in normal pregnancy and its diagnostic efficacy in patients with gestational hypertension, gestational diabetes mellitus, or preeclampsia.
    Xie X; Wang M; Lu Y; Zeng J; Wang J; Zhang C; Zhu H; Song Y; Han L; Liu Y; Zhang J; Li L; Chen L; Zhai Y; Cao Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23623. PubMed ID: 33067885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental hypoplasia and maternal organic vascular disorder in pregnant women with gestational hypertension and preeclampsia.
    Owaki Y; Watanabe K; Iwasaki A; Saitou T; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):353-359. PubMed ID: 30983440
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
    Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio.
    Karge A; Seiler A; Flechsenhar S; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B; Graupner O
    Pregnancy Hypertens; 2021 Jun; 24():37-43. PubMed ID: 33647841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
    Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.